Navigating Clinical Drug Interactions in Multimorbid Patients
Author: Mr. Junaed Alom • RxInk Editorial Board
Polypharmacy poses an escalating challenge across modern critical care and geriatric clinics. When patients present with cardiovascular comorbidities alongside diabetic nephropathy, balancing therapeutic index against metabolic drug-drug interactions necessitates rigorous pharmacokinetic scrutiny.
The Role of Cytochrome P450 Isoenzymes
Competitive inhibition of CYP3A4 and CYP2C9 accounts for over 65% of preventable adverse drug reactions recorded in hospital intensive care units. Clinicians must leverage contemporary therapeutic drug monitoring (TDM) and structured dosage titration protocols.